Form 8-K - Current report:
SEC Accession No. 0001193125-25-151511
Filing Date
2025-06-27
Accepted
2025-06-27 17:29:38
Documents
13
Period of Report
2025-06-24
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d848617d8k.htm   iXBRL 8-K 26983
2 EX-4.1 d848617dex41.htm EX-4.1 224261
  Complete submission text file 0001193125-25-151511.txt   412587

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iobt-20250624.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20250624_lab.xml EX-101.LAB 17910
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20250624_pre.xml EX-101.PRE 11238
15 EXTRACTED XBRL INSTANCE DOCUMENT d848617d8k_htm.xml XML 3615
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 251088077
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)